Covid-19 manufacturing roundup: EMA clears 2 New England manufacturing sites for Covid-19 vaccine scale up; Incentives, tax breaks highlight South Korea's efforts to be vaccine powerhouse
The EMA has approved a scale-up of production of Moderna’s Covid-19 vaccine Spikevax at two New England sites.
If all goes according to plan, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
